Zai Lab Ltd ZLAB

About Zai Lab Ltd (ZLAB): stock profile, AI score and financials

Zai Lab Ltd (ZLAB) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ZLAB at 36.3/100 on a composite quality score built from its SEC filings, placing it at rank #2,262 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Zai Lab Ltd reports quarterly revenue of $106.3M, net income of $-50.8M, an operating margin of -72.0%. Top institutional holders of ZLAB by reported 13-F value include RTW INVESTMENTS, TCG Crossover Management, RA CAPITAL MANAGEMENT, L.P., based on the most recent SEC filings. ZLAB trades on the Nasdaq exchange and files with the SEC under CIK 1704292. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ZLAB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Zai Lab Ltd directly from SEC EDGAR.

SEC EDGAR: CIK 1704292 →